Obagi Medical Products, Inc. (OMPI) Tops Q2 EPS by 4c

August 2, 2012 5:33 PM EDT
Get Alerts OMPI Hot Sheet
Trade OMPI Now!
Join SI Premium – FREE
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.39 million.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment